Orlifit®

Orlifit®

Therapeutic Segment: Anti-Obesity

Generic Name: Orlistat

Indication:

For the long-term obesity management including weight loss, weight maintenance together with a reduced
calorie diet and for reducing the risk of weight regain after weight loss in patients with initial BMI of 30kg/m² or greater. with initial BMI of 28kg/m² or more in the presence of other risk factors ( e. g., hyper tension, diabetes, dyslipidemia).

Available as:

Capsules
  • 120MG